SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1504 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Exonhit S.A.. (6/5/12). "Press Release: Exonhit Receives € 1.93 Million from OSEO within the Personalized Medicine TEDAC Project in Cancer. Financing of € 1,928,000 through both Grants and Redeemable Advances". Paris. 2012-06-05
Hybrigenics S.A.. (6/4/12). "Press Release: Hybrigenics Reports Initial Results from Clinical Phase 2 Trial of Oral Inecalcitol in Moderate to Severe Psoriasis". Paris. 2012-06-04
Alizé Pharma. (6/4/12). "Press Release: Alizé Pharma Closes 3.3 Million Euro Funding Round". Lyon. 2012-06-04
Cellectis S.A.. (5/21/12). "Press Release: Cellectis Stem Cells Today Proudly Announces the Launch of the World’s Very First Human iPS Cell-derived Hepatocyte Product". Gothenburg. 2012-05-21
Genfit. (5/2/12). "Press Release: Reserved Capital Increase. YA Global Master SPV Ltd, Managed by the Investment Company Yorkville Advisors LLC, Invests a Further €600 K". Lille & Cambridge, MA. 2012-05-02
Theradiag S.A.. (5/2/12). "Press Release: Biomedical Diagnostics (BMD) Becomes Theradiag and Moves into Theranostics". Paris. 2012-05-02
Genfit. (4/25/12). "Press Release: Annual Results for 2011". Lille & Cambridge, MA. 2012-04-25
Nanobiotix. (4/24/12). "Press Release: Nanobiotix Appoints Bernd Mühlenweg as a Member of the Executive Board". Paris. 2012-04-24
Novasep S.A.. (4/23/12). "Press Release: Novasep Strenghtens Its Management Team with the Appointment of Jean-Claude Romain as Corporate Quality Director and Alain Lamproye as Director of Novasep Bioproduction Site in Belgium". Pompey. 2012-04-23
Immutep S.A.. (4/10/12). "Press Release: Immutep and Lonza Sign Agreement for Cell Line Selection, Cell Banking and Process Development of ImmuFact IMP321". Basel & Orsay. 2012-04-10
Cellectis S.A.. (4/2/12). "Press Release: Appointment of Mathieu Simon, MD, to the Position of Senior Vice President of Cellectis Group". Paris. 2012-04-02
Vivalis S.A.. (3/29/12). "Press Release: Vivalis 2011 Results. Continuing Growth Momentum". Nantes & Lyon. 2012-03-29
Omnes Capital S.A.S.. (3/29/12). "Press Release: Crédit Agricole Private Equity Becomes Omnes Capital". 2012-03-29
Novasep S.A.. (3/27/12). "Press Release: Novasep Opens New 2,000 m² Expanded Shanghai Facilities to Meet Increasing East Asia Demand". Pompey & Shanghai. 2012-03-27
Hybrigenics S.A.. (3/27/12). "Press Release: Hybrigenics Completed Its Private Placement to Institutional Investors up to EUR 3.3 Million". Paris. 2012-03-27
Cellectis S.A.. (3/23/12). "Press Release: 2011 Full-year Earnings. Growth Strategy Stepped Up – 22% Sales Growth". Paris. 2012-03-23
Enterome Bioscience S.A.. (3/22/12). "Press Release: Enterome Raises EUR Five Million in Series A Funding Round. Funding Enables further Development of Unique Metagenomic Technology and Solutions for Gut Microbiota-related Diseases Affecting a Large Prop 2012-03-22
Novasep S.A.. (3/21/12). "Press Release: Novasep Announces Major Recapitalization to Boost Its Growth. A Strongly Improved Balance Sheet, New Shareholders and an Entrepreneurial Management to Support the Group’s Development Going Forward". Pompey. 2012-03-21
Nicox S.A.. (3/21/12). "Press Release: NicOx Enters into Option Agreement to Acquire Altacor as a First Step Towards Building an International Ophthalmology Business". Sophia Antipolis. 2012-03-21
Adocia S.A.. (3/15/12). "Press Release: Adocia Increase the Size of Its Initial Public Offering to €27.4 Million through the Partial Exercise of the Overallotment Option [Not to Be Published in United States of America, Canada, Australia , Italy or Japan 2012-03-15
Vivalis S.A.. (3/13/12). "Press Release: Vivalis Announces the Signature of a Broad Collaboration Agreement and Commercial License for the Use of the EB66 Cell Line for the Production of a Monoclonal Antibody". Nantes & Lyon. 2012-03-13
IntegraGen S.A.. (3/6/12). "Press Release: 45% Growth of Genomic Services in 2011 – IntegraGen Becomes the First French Services Lab Equipped with an Illumina MiSeq". Evry. 2012-03-06
Exonhit S.A.. (3/5/12). "Press Release: Exonhit Is Beneficiary of a Grant from the European Union within the RESPONSIFY Consortium. € 418,000 Grant – European Personalized Medicine Consortium with 12 Partners". Paris. 2012-03-05
Adocia S.A.. (2/14/12). "Press Release: Adocia Carris Out, with much Success, the First IPO of the Year on the NYSE Euronext Paris Regulated Market [This document may not be published, distributed or disseminated, directly or indirectly, in the United St 2012-02-14
Alizé Pharma. (2/2/12). "Press Release: Alizé Pharma Licenses Its Asparec Therapy for Treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma". Lyon. 2012-02-02
Hybrigenics S.A.. (1/30/12). "Press Release: Hybrigenics Revenues Grew 45% to EUR 6.6 Million in 2011. Hybrigenics Services Contributed for EUR 4.1 Million, a 17% Growth". Paris. 2012-01-30
Domain Therapeutics S.A.. (1/30/12). "Press Release: Domain Therapeutics Awarded Grant from The Michael J. Fox Foundation for the Development of Novel mGluR3 PAM Compounds to Treat Parkinson’s Disease". Strasbourg. 2012-01-30
Stentys S.A.. (1/25/12). "Press Release: Stentys Launches a Private Placement of Up to 10% of Capital". Paris. 2012-01-25
Vivalis S.A.. (1/24/12). "Press Release: Strong Revenue Growth – +112%. Initation of a Third Antibody Discovery Program with Sanofi Pasteur". Nantes & Lyon. 2012-01-24
Vivalis S.A.. (1/23/12). "Press Release: Opening of a New Laboratory Dedicated to the Viva|Screen Antibody Discovery Platform". Nantes, Lyon & Toyama. 2012-01-23
Hybrigenics S.A.. (1/19/12). "Press Release: Hybrigenics Targets Chronic Lymphocytic Leukemia (CLL) as the Third Therapeutic Indication for Its Oral Inecalcitol". Paris. 2012-01-19
Adocia S.A.. (1/18/12). "Press Release: Within the Framework of Its Planned IPO on the Regulated Market of NYSE Euronext in Paris, Adocia Announces the Registration of Its »Document de Base« by the Autorité des Marchés Financiers [Not for US, CA, AU, IT 2012-01-18
Publicis Groupe S.A.. (1/18/12). "Press Release: Publicis Groupe Acquires Mediagong, One of France’s Most Innovative Digital Agencis. Leo Burnett France Will Benefit from Startup’s Digital Smarts". Paris. 2012-01-18
Polyplus-transfection S.A.. (1/18/12). "Press Release: Polyplus-transfection Launches the Next Generation PEI Transfection Reagent for Bioproduction. PEIpro Further Expands an Already Rich Catalogue of Innovative Reagents". Strasbourg. 2012-01-18
Vivalis S.A.. (1/17/12). "Press Release: Vivalis and Sanofi Pasteur Extend Their 2010 Collaboration and License Contract with a New Human Monoclonal Antibody Discovery Target against a New Infectious Disease". Nantes, Lyon & Toyama. 2012-01-17
Novalix S.A.S.. (1/12/12). "Press Release: Novalix Enters into Multi-target Integrated Drug Discovery Collaboration with Teijin Pharma". Strasbourg. 2012-01-12
Cellectis S.A.. (1/9/12). "Press Release: Cellectis Launches a Partnership with Total for Exploratory Research into Microalgae-based Substitutes for Oil Products". Paris. 2012-01-09
Transgene S.A.. (12/21/11). "Press Release: Transgene and Jennerex Announce First Patient Treated in Phase 2a Clinical Trial of JX594/TG6006 in Colorectal Cancer Patients. Product to Be Used as Neoadjuvant Therapy to Patients Undergoing Surgery". Strasbo 2011-12-21
Genopharm. (12/20/11). "Press Release: Suspension of Genopharm and Alkopharm Laboratories. AFSSAPS Keep Going Administratively at Two Laboratories to Avoid Going Back on a Decision, Seriously Striking a Blow at the Public Health". 2011-12-20
Hybrigenics S.A.. (12/19/11). "Press Release: Hybrigenics Completes Enrolment of Its Phase II Clinical Trial of Inecalcitol in Psoriasis. Sixty Patients Have Successfully Been Enrolled in Six Weeks". Paris. 2011-12-19
Sanofi S.A.. (12/19/11). "Press Release: Sanofi Completes Divestiture of Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.". Paris. 2011-12-19
Transgene S.A.. (12/16/11). "Press Release: Transgene and the French League against Cancer Enter Partnership to Accelerate Research and Development of New Anticancer Biotherapies". Strasbourg. 2011-12-16
Crédit Agricole S.A.. (12/16/11). "Press Release: Crédit Agricole S.A. and Coller Capital Announce Agreement for the Sale of Crédit Agricole Private Equity". Montrouge. 2011-12-16
Trophos S.A.. (12/13/11). "Press Release: Trophos Announces Results of Phase 3 Study of Olesoxime in Amyotrophic Lateral Sclerosis". Marseille. 2011-12-13
Cytoo S.A.. (12/12/11). "Press Release: Cytoo, Cenix BioScience and Academic Collaborators Bioquant, EPFL and FTMC Receive a 4 M€ EU FP7 Grant to Launch MEHTRICS Consortium". 2011-12-12
Cellectis S.A.. (12/8/11). "Press Release: Cellectis Bioresearch and Syngene Announce Partnership on the Development of Customized Cell Lines". Paris & Bangalore. 2011-12-08
Cellectis S.A.. (12/5/11). "Press Release: Cellectis Signs a License Agreement Under Patents Covering Uses of Homologous Recombination with Global Pharmaceutical Company". Paris. 2011-12-05
EBD Group. (12/1/11). "Press Release: EuroMedtech 2012 Looks to Set New Benchmark for Productive Partnering". Zurich & Grenoble. 2011-12-01
ComplexINC project. (12/1/11). "Press Release: Launch of New EU-funded Project – ComplexINC. It’s an SME-targeted Collaborative Project in FP7 Regarding New Technologies and Production Tools for Complex Protein Biologics". 2011-12-01
Ipsen S.A.. (11/28/11). "Press Release: Ipsen’s Partner Inspiration Biopharmaceuticals Announces the Initiation of the Second Phase III Pivotal Clinical Study of OBI-1 in Congenital Hemophilia A with Inhibitors". Paris. 2011-11-28
Cerenis Therapeutics S.A.. (11/22/11). "Press Release: Cerenis Appoints John F. Paolini as Chief Medical Officer. Internationally Recognized Expert Brings over 15 Years of Experience in Drug Development and Commercialisation to Treat Cardiovascular Disea 2011-11-22
Cerenis Therapeutics S.A.. (11/22/11). "Press Release: The Board of Cerenis Appoints Dr. Richard C. Pasternak as Non Executive Director. Internationally Recognized Expert Brings over 30 Years of Experience in the Field of Cardiovascular Disease". Toulous 2011-11-22
Cytoo S.A.. (11/21/11). "Press Release: Cytoo Raises 10 M$ (7M€) in Series C Round". Grenoble. 2011-11-21
Hybrigenics S.A.. (11/21/11). "Press Release: Hybrigenics Starts Phase II Clinical Trial of Inecalcitol in Psoriasis. Twenty Patients Have Already Been Enrolled in the First Two Weeks of the Study". Paris. 2011-11-21
Sanofi. (11/10/11). "Press Release: Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia". Paris & Tarrytown, NY. 2011-11-10
Prognomix Inc.. (11/8/11). "Press Release: Servier Enters into a Type 2 Diabetes Partnership with Canadian Firm Prognomix Inc.". Suresnes & Montréal. 2011-11-08
Cellectis S.A.. (11/4/11). "Press Release: Cellectis Announces the Final Completion of the Acquisition of Cellartis and €50 Million Financing Round Reserved for the FSI and Mr. Pierre Bastid". 2011-11-04
Eurofins Scientific. (11/2/11). "Press Release: Eurofins Announces Successful Closing of the Transaction for a Majority Stake in IPL SED Nord and IPL Invest". 2011-11-02
Cellectis S.A.. (11/2/11). "Press Release: Cellectis Shareholders Approve the Acquisition of Cellartis. Cellectis Decides to Raise €50 Million from the FSI and Mr. Pierre Bastid, ant to Grant Free Share Purchase Warrants to All Existing Shareholders". Pa 2011-11-02
Poxel S.A.. (10/26/11). "Press Release: New Clinical Results for an Anti-diabetic Compound in Development at Poxel". 2011-10-26
Cellectis S.A.. (10/24/11). "Press Release: Appointment of Philippe Valachs as Cellectis’ General Secretary". Paris. 2011-10-24
Sartorius Stedim Biotech S.A.. (10/20/11). "Press Release: New Dimensions in Flexel for Magnetic Mixers. Sartorius Stedim Biotech Presents 1,500 L and 2,000 L Standard Single-use Mixing Systems for Large Volumes". Göttingen & Aubagne. 2011-10-20
Ipsen S.A.. (10/20/11). "Press Release: Syntaxin and Ipsen Enter into a Strategic Agreement to Develop Novel Botulinum-toxin Therapeutics. Collaboration to Leverage Syntaxin and Ipsen’s Expertise in the Discovery and Development of Botulinum Toxins". Par 2011-10-20
Hybrigenics S.A.. (10/10/11). "Press Release: Hybrigenics and Servier Enter into a License and Research Collaboration Agreement in Oncology and Other Therapeutic Fields. Hybrigenics Will Receive €4 Million over 3 Years". Paris & Suresnes. 2011-10-10
Cellectis S.A.. (10/6/11). "Press Release: Cellectis – 2011 Half-year Results. Recources Strengthened to Support Growth Across All the Group’s Business Lines, with Limited Cash Burn – Important Strategic Moves Implemented". Paris. 2011-10-06
Hybrigenics S.A.. (10/5/11). "Press Release: Hybrigenics Appoints Dr. Alain Munoz to Its Board of Directors". Paris. 2011-10-05
Eurofins Scientific. (10/3/11). "Press Release: Eurofins Signs Definitive Agreement to Acquire Majority Stakes in Institut Pasteur de Lille Subsidiaries, IPL SED Nord and IPL Invest". 2011-10-03
Cellectis S.A.. (10/3/11). "Press Release: Cellectis Issues Statement Regarding Patent Suits on Meganuclease Technology". Paris. 2011-10-03
Novagali Pharma S.A.. (9/28/11). "Press Release: Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.". Osaka & Évry. 2011-09-28
Cellectis S.A.. (9/26/11). "Press Release: The ETICS Project, Led by Cytoo in Collaboration with Cellectis Bioresearch and the CEA, to Receive €7.6m in Funding from OSEO. A Collaboration to Develop Highly Innovative Kits for Pharmaceutical Research". Par 2011-09-26
Eurofins Scientific. (9/23/11). "Press Release: Eurofins Announces the Inauguration of Its Nantes Laboratory Extension Turning into the Largest Single-site Independent Food Testing Laboratory in the World". 2011-09-23
Cellectis S.A.. (9/15/11). "Press Release: Cellectis Announces Its Upcoming Acquisition of Cellartis, the European Stem Cell Leader, in Conjunction with a Fund Raising Subscribed by the FSI and Pierre Bastid". Paris. 2011-09-15
Cellectis S.A.. (9/7/11). "Press Release: Cellectis Announces a Ten-fold Increase in Nuclease Production Capacity in 2011 – Significantly Expands Potential for Technology Adoption Worldwide". Paris. 2011-09-07
Photonis Holding S.A.S.. (9/7/11). "Press Release: Axa Private Equity Acquires Photonis from Astorg Partners". Paris. 2011-09-07
PX’Therapeutics S.A.. (9/6/11). "Press Release: PX’Therapeutics Licenses Ribovax’s SEBVI Technology for the Development and Manufacturing of Fully Human Monoclonal Antibodies". 2011-09-06
Ipsen S.A.. (8/30/11). "Press Release: Appointments to Ipsen’s Executive Committee. Nathalie Joannes Is Nominated Executive Vice President, General Counsel and Susheel Surpal Is Nominated Executive Vice President, Chief Financial Officer". Paris. 2011-08-30
Novalix S.A.S.. (8/29/11). "Press Release: Novalix and Galapagos Collaborate in Osteroarthritis Discovery Research". Strasbourg. 2011-08-29
Cellectis S.A.. (8/24/11). "Press Release: Cellectis Bioresearch Grants Recombinetics an Exclusive License Agreement for the Use of Targeted Nucleases in Large Livestock". Paris & Minneapolis, MN. 2011-08-24
Transgene S.A.. (8/23/11). "Press Release: Transgene Publishes Phase I Clinical Data of Its HCV Immunotherapy Product in Journal »Gastroenterology« and Announces Future Communication at AASLD". Strasbourg. 2011-08-23
InProcess Instruments Gesellschaft für Prozessanalytik mbH. (8/18/11). "Press Release: InProcess Instruments Presents French Website". 2011-08-18
bioMérieux S.A.. (7/22/11). "Press Release: Completion of the AES Chemunex Group Acquisition and Filing of a Tender Offer for the AES Chemunex Shares". Marcy l’Étoile. 2011-07-22
Cellectis S.A.. (7/20/11). "Press Release: Cellectis Bioresearch and Lonza Achieve Significant Milestone on CHO-K1SV GS Knock-out". Paris & Basel. 2011-07-20
Eurofins Scientific. (7/20/11). "Press Release: Eurofins Signs an Exclusive Agreement with the Fondation Institut Pasteur de Lille towards a Partnership in the Environmental Testing Field". 2011-07-20
bioMérieux S.A.. (7/19/11). "Press Release: bioMérieux Expands Its Infectious Disease Offering with Acquisition of Argene, Specialized in Molecular Diagnostics for Immunocompromised Patients". Marcy l’Étoile. 2011-07-19
Cellectis S.A.. (7/11/11). "Press Release: Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis Therapeutics". Paris. 2011-07-11
Cellectis S.A.. (7/5/11). "Press Release: TALEN Access by Cellectis Bioresearch Receives »Most Innovative New Service 2011« Award at Life Science Awards". Paris. 2011-07-05
Cellectis S.A.. (6/29/11). "Press Release: Cellectis and Pregenen Sign Collaboration Agreement for the Development of Meganucleases". Paris & Seattle, WA. 2011-06-29
Cellectis S.A.. (6/27/11). "Press Release: André Choulika to Serve as both Chairman and CEO of Cellectis". Paris. 2011-06-27
Sedere. (6/27/11). "Press Release: Product. Release of the New Sedex LT-ELSD Model 90LT". 2011-06-27
Roche. (6/23/11). "Press Release: Roche Sets Up R&D Institute in France to Foster Collaborative Translational Research. Focus on Creation and Expansion of Strategic Partnerships with Leading French Academic Centers". Basel. 2011-06-23
bioMérieux S.A.. (6/22/11). "Press Release: bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety". Marcy l’Étoile. 2011-06-22
Ipsogen S.A.. (6/15/11). "Press Release: Ipsogen Receives an Offer from Qiagen to Fully Acquire Ipsogen and Enters into Exclusive Negotiations". Marseille. 2011-06-15
Ipsen S.A.. (6/9/11). "Press Release: Increase Focus, Invest to Grow, Leverage Footprint [Ipsen Strategy Day]". Paris. 2011-06-09
Ipsen S.A.. (6/9/11). "Press Release: Strategy Day. Presentation". Paris. 2011-06-09
Ipsogen S.A.. (6/7/11). "Press Release: EHA 2011. Ipsogen to Present Its First Multicentre Study on the IS-MMR BCR-ABL Assay". Marseille. 2011-06-07
Cellectis S.A.. (6/6/11). "Press Release: Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection". Paris & Evry. 2011-06-06
Ipsogen S.A.. (5/30/11). "Press Release: Ipsogen to Present Two Studies on the Genomic Grade Test at ASCO 2011 in Chicago, Ill, USA". Marseille. 2011-05-30
bioMérieux S.A.. (5/19/11). "Press Release: bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition". Marcy l’Étoile. 2011-05-19
Cellectis S.A.. (5/18/11). "Press Release: Cellectis Bioresearch Appoints Wako as Exclusive Distributor of Its genome Customization Solutions in Japan. Collaboration Includes Distribution of Recently Launched TALEN Access". Paris & Osaka. 2011-05-18
Advanced Chemistry Development, Inc. (ACD/Labs). (5/17/11). "Press Release: LABERCA, France’s National Reference Laboratory for Food Residues and Contaminants, to Employ ACD/Labs MS Products". Toronto. 2011-05-17
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUK] – The Business Web Portal 600x80px

» top